Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters
Database
Language
Document Type
Year range
1.
Tissue Plasminogen Activator in Critically Ill Adults with COVID-19.
Douin, David J; Shaefi, Shahzad; Brenner, Samantha K; Gupta, Shruti; Park, Isabel; Wright, Franklin L; Mathews, Kusum S; Chan, Lili; Al-Samkari, Hanny; Orfanos, Sarah; Radbel, Jared; Leaf, David E.
Ann Am Thorac Soc ; 18(11): 1917-1921, 2021 11.
Article in English | MEDLINE | ID: covidwho-1191153

Subject(s)
COVID-19 Drug Treatment , Tissue Plasminogen Activator , Adult , Critical Illness , Humans , Tissue Plasminogen Activator/therapeutic use
2.
Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space.
Orfanos, Sarah; El Husseini, Ibrahim; Nahass, Thomas; Radbel, Jared; Hussain, Sabiha.
ERJ Open Res ; 6(4)2020 Oct.
Article in English | MEDLINE | ID: covidwho-845497

ABSTRACT

#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a.

SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL